Charles Sermon
Patrimonio netto: 75 138 $ in data 31/07/2026
Patrimonio netto: 75 138 $ in data 31/07/2026
Charles Edward Sermon is the founder of Mereo BioPharma Group Plc, founded in 2015, holding the title of Secretary, General Counsel & Business Development.
Current jobs include Director at Mereo BioPharma 3 Ltd., Director at Mereo BioPharma 2 Ltd. since 2015, Director at Mereo BioPharma 4 Ltd. since 2017, and Trustee at Rainbow Trust Children's Charity.
Former jobs include Partner at Phase4 Partners Ltd. from 2000 to 2022, Member-Digital, Creative & Science at London Enterprise Panel from 2013 to 2016, and a position at Freshfields in 2004.
Education includes graduation from The University of Hull.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 26/03/2026 | 1.095.309 ( 0,14% ) | 75 138 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Fondatore | 01/03/2015 |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Direttore/Membro del Consiglio | - |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Direttore/Membro del Consiglio | 30/06/2015 |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Direttore/Membro del Consiglio | 24/10/2017 |
Rainbow Trust Children's Charity
Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Membro del Comitato di Investimento | 28/02/2022 |
London Enterprise Panel | Corporate Officer/Principal | 01/01/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
The University of Hull
The University of Hull Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rainbow Trust Children's Charity
Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services | Commercial Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
London Enterprise Panel | |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Health Technology |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Commercial Services |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale